Michael Duruisseaux: Toxicities associated with sequential or combined use of small targeted therapies in lung cancer

Michael Duruisseaux, Thoracic Oncologist at HCL – Hospices Civils de Lyon, shared on X:

“Hot of the press: very pleased to share this team work “Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in lung cancer”.

Led by Thomas Pierret and Dr Desage.”

Source: Michael Duruisseaux/X

Authors: Anne-Laure Désage, Michael Duruisseaux, Claire Lafitte, Sophie Bayle-Bleuez, Christos Chouaid. Pierre Fournel, Thomas Pierret

Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in non-small cell lung cancer: A critical review of the literature